Mucoplant (Dry Extract Of Hederae Folium (Der 4-8:1), Extracting Agent: Ethanol 30 % (M/M))

The extract contains saponins and flavonoids that stimulate the glands of the bronchial mucosa, increase serous fluid production, reduce mucus viscosity and enhance ciliary movement. These actions together help loosen secretions and make them easier to cough up.

The appropriate dose of Mucoplant is determined by the prescribing healthcare professional based on the individual’s age, condition severity and overall health. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Mucoplant in pregnancy and lactation are limited. It should be avoided unless the potential benefit justifies the possible risk to the fetus or infant, and only under medical supervision.

To order Mucoplant, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mucoplant is a plant‑derived expectorant, whereas many alternatives are synthetic mucolytics or combination products. Its active ivy leaf extract offers a natural mechanism of increasing bronchial secretions, which may be preferred by patients seeking herbal options, though efficacy and safety profiles should be compared with a healthcare provider.

Store Mucoplant at ambient temperature, preferably below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and heat sources to preserve potency and prevent degradation.

Mucoplant is taken orally, usually as a tablet or capsule, with a glass of water. It should be swallowed whole unless the prescriber advises otherwise, and taken at the times recommended by the healthcare professional.

Serious adverse reactions, although rare, include anaphylactic shock, severe bronchospasm and significant liver enzyme elevation. Patients experiencing difficulty breathing, swelling of the face or throat, or jaundice should seek immediate medical attention.

Mucoplant should be avoided by individuals with known hypersensitivity to ivy (Hedera) or any of its constituents, by patients with uncontrolled asthma prone to bronchospasm, and by pregnant or breastfeeding women unless a physician determines that the benefit outweighs the risk.